Supply Chain

Here are the four latest drugs and medical devices approved by the Food and Drug Administration in the past week.

The Food and Drug Administration on Wednesday approved Pentax of America's new duodenoscope, which features a disposable distal cap to improve device cleaning and reprocessing.

Giving patients access to Novartis' $475,000 breakthrough leukemia therapy — an extremely expensive but highly effective treatment — is going to take novel collaboration, Express Scripts CMO Steve Miller, MD, wrote in a blog post on the company's website.

Researchers at Baltimore-based Johns Hopkins University broke a record for the longest distance traveled by a medical drone carrying blood samples, according to a HealthDay report.

Here are five articles published by Becker's Hospital Review in the last week, featuring Amazon's rumored discussions with pharmacy benefit managers and rural hospitals' struggle to stock drugs blocked from 340B discounts, among other topics.

Pfizer on Wednesday filed an antitrust suit against Johnson & Johnson, claiming the drugmaker's "exclusionary contracts" with insurers and hospitals unfairly blocked competition for J&J's arthritis drug Remicade, reports The Wall Street Journal.

An Alaska union-benefits fund filed a federal lawsuit Monday against Abbott Laboratories, claiming the company' subsidiary, St. Jude Medical, failed to warn regulators and patients about defective lithium batteries in its defibrillators for years, reports StarTribune.

Amazon is reportedly communicating with pharmacy benefit managers about potential drug contracts, according to a Leerink Partners analysis cited by CNBC.

The world has a severe lack of new antibiotics being developed to combat antimicrobial resistance, according to a recent report by the World Health Organization.

The FDA approved United Kingdom-based GlaxoSmithKline's Trelegy Ellipta, a once-daily inhaler that contains three medicines for chronic obstructive pulmonary disease.